Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TSHR | P16473 | 4/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30996206 | 0.80 | CA2 (0.44) | KIF11ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL29585116 | 0.77 | ALDH1A1 (0.44) | MAPTALDH1A1TSHRHSD17B10CYP2A6 | |
| SCHEMBL1925928 | 0.77 | ALDH1A1 (0.44) | MAPTALDH1A1TSHRHSD17B10CYP2A6 | |
| SCHEMBL3089174 | 0.76 | GABRA1 (0.43) | ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL16990195 | 0.74 | CA2 (0.39) | KIF11ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL27699133 | 0.73 | CA2 (0.38) | KIF11ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL4124570 | 0.71 | HSD17B10 (0.46) | KIF11MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL1925715 | 0.71 | HSD17B2 (0.39) | KIF11MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL29583541 | 0.71 | HSD17B2 (0.39) | KIF11MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL9624177 | 0.70 | HSD17B10 (0.44) | KIF11MAPTALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7642357-B2 | Iridium complexes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-01-05 | — | — | US | disclosed |
| US-20090036696-A1 | IRIDIUM COMPLEXES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-0478147-A1 | Process for producing optically active gamma-butyrolactone derivatives | Takasago International Corporation (JP) | 1992-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036696-A1 | IRIDIUM COMPLEXES | HAX1, MLX, H1-0 | KIF11 3305/4885MAPT 4800/4885ALDH1A1 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.